Stay updated on ASCEND Clinical Trial: Symptom Evaluation in Depression
Sign up to get notified when there's something new on the ASCEND Clinical Trial: Symptom Evaluation in Depression page.

Latest updates to the ASCEND Clinical Trial: Symptom Evaluation in Depression page
- Check7 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 appears on the page; it is a minor UI/version detail and does not affect the study information.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedLocations section reorganized under a single header, with California, Florida, and Washington listed as study sites.SummaryDifference0.5%

- Check56 days agoChange DetectedAdded a note that PubMed publications are automatically filled from PubMed and may not be about the study, with Revision: v3.3.2. Removed the previous wording stating that PubMed publications are automatically created by ClinicalTrials.gov Identifier (NCT Number) and may or may not be about the study, with Revision: v3.2.0.SummaryDifference0.1%

- Check64 days agoChange DetectedThe funding/operating status notice on the page has been removed, eliminating information about potential delays and NIH operations; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check78 days agoChange DetectedThe page shows a redesigned layout while preserving all core study information (title, design, eligibility, outcomes, and locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check107 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference5%

Stay in the know with updates to ASCEND Clinical Trial: Symptom Evaluation in Depression
Enter your email address, and we'll notify you when there's something new on the ASCEND Clinical Trial: Symptom Evaluation in Depression page.